Clinical Phase Ib/II Trial of L-NMMA Plus Docetaxel in the Treatment of Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date8/1/16 → …